References
- Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
- Yalkowsky SH. Solubility and solubilization in aqueous media. New York: Oxford University Press; 1999.
- Bansal AK, Khar RK, Dubey R, Sharma AK. Activity profile of glycolamide ester prodrugs of ibuprofen. Drug Dev Ind Pharm 2001;27:63–70.
- Fini A, Fazio G, Feroci G. Solubility and solubilisation properties of non-steroidal anti-inflammatory drugs. Int J Pharm 1995;126:95–102.
- Lindenberg M, Knopp S, Dressman JB. Classification of orally administered drugs on the world health organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004;58:265–78.
- Nagane K, Kimura S, Ukai K, et al. Practical approach to prepare solid dispersion drug product using spherical silicate. Int J Pharm 2014;475:364–371.
- Zhang P, Forsgren J, Strømme MP. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs. Int J Pharm 2014;472:185–191.
- Rossmann M, Braeuer A, Schluecker E. Supercritical antisolvent micronization of PVP and ibuprofen sodiumtowards tailored solid dispersions. J Supercrit Fluids 2014;89:16–27.
- Plakkot S, de Matas M, York P, et al. Comminution of ibuprofen to produce nanoparticles for rapid dissolution. Int J Pharm 2011;415:307–314.
- Sinha B, Müller RH, Möschwitzer JP. Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals. Int J Pharm 2013;458:315–323.
- Kocbek P, Baumgartner S, Kristl JP. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm 2006;312:179–186.
- Wang Z, Chen JF, Le Y, Shen ZG. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind Eng Chem Res 2007;46:4839–4845.
- Lechuga-Ballesteros D, Rodriguez-Hornedo N. Effects of molecular structure and growth kinetics on the morphology of L-alanine crystals. Int J Pharm 1995;115:151–160.
- Raghavan SL, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001;212:213–221.
- Zimmermann A, Millqvist-Fureby A, Elema MR, et al. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. Eur J Pharm Biopharm 2009;71:109–116.
- Alhnan MA, Basit AW. In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions. J Pharm Sci 2011;100:3284–3293.
- Lindfors L, Forssén S, Westergren J, Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci 2008;325:404–413.
- Anhalt K, Geissler S, Harms M, et al. Development of a new method to assess nanocrystal dissolution based on light scattering. Pharm Res 2012;29:2887–2901.
- De Smet L, Saerens L, De Beer T, et al. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs. Eur J Pharm Biopharm 2014;87:107–113.